The United States Bioconjugation Market is witnessing substantial growth due to increasing investments in biopharmaceutical research, rising adoption of targeted therapies, and expanding applications of antibody-drug conjugates across multiple therapeutic areas. The presence of leading biotechnology companies, pharmaceutical manufacturers, and advanced research institutions continues to drive...